openPR Logo
Press release

Global Opioid Receptor Agonist Market Research Report 2023-2029

09-26-2023 04:52 AM CET | Advertising, Media Consulting, Marketing Research

Press release from: QY Research Inc.

Global Opioid Receptor Agonist Market Research Report

Opioids are a type of painkiller that works by acting on the neurological system. They're mostly utilized for anaesthetic and pain relief. An agonist is a pharmacological molecule that activates specific brain receptors. When only a small number of receptors are engaged, this agonist elicits a strong physiological/pharmacological response, indicating that the medication has high intrinsic activity. Fentanyl, morphine, dihydromorphinone, meperidine, oxycodone, and oxymorphone are all strong agonist opioids. Opioid receptors are G-protein-coupled inhibitors that are primarily found in peripheral tissues and interfere with opioid receptors' pain-signaling function. Agonists are pain relievers that function by binding opioid receptors and reducing pain experience.

Global Opioid Receptor Agonist Market: Driven factors and Restrictions factors
The research report encompasses a comprehensive analysis of the factors that affect the growth of the market. It includes an evaluation of trends, restraints, and drivers that influence the market positively or negatively. The report also outlines the potential impact of different segments and applications on the market in the future. The information presented is based on historical milestones and current trends, providing a detailed analysis of the production volume for each type from 2018 to 2029, as well as the production volume by region during the same period.

Global Leading Market Research Publisher QYResearch announces the release of the report "Global Opioid Receptor Agonist Market Report, History and Forecast 2018-2029, Breakdown Data by Manufacturers, Key Regions, Types and Application". Based on historical analysis (2018-2022) and forecast calculations (2023-2029), this report provides a detailed analysis of the production volume for each type from 2018 to 2029, as well as production by region during the same period. It aims to help readers gain a comprehensive understanding of the global Opioid Receptor Agonist market with multiple angles, which provides sufficient supports to readers' strategy and decision making. As the market is constantly changing, the report explores competition, supply and demand trends, as well as the key factors that contribute to its changing demands across many markets.

Get a free sample PDF of this report (Including Full TOC, List of Tables & Figures, Chart) :
https://www.qyresearch.com/reports/1349217/opioid-receptor-agonist
Overall, this report will provide you with the insights and information needed to make informed business decisions and stay ahead of the competition.

Global Opioid Receptor Agonist Market report also includes a pricing analysis for each type, manufacturer, region, and global price from 2018 to 2029. This information will help stakeholders make informed decisions and develop effective strategies for growth. The report's analysis of the restraints in the market is crucial for strategic planning as it helps stakeholders understand the challenges that could hinder growth. This information will enable stakeholders to devise effective strategies to overcome these challenges and capitalize on the opportunities presented by the growing market. Furthermore, the report incorporates the opinions of market experts to provide valuable insights into the market's dynamics. This information will help stakeholders gain a better understanding of the market and make informed decisions.

The Opioid Receptor Agonist market is segmented as below:
By Company
Teva Pharmaceutical Industries
Johnson & Johnson
Pfizer
Fresenius Kabi
Mylan N.V.
Allergan
US WorldMeds
Piramal Critical Care
DAIICHI SANKYO COMPANY
Purdue Pharma
Hikma Pharmaceuticals
Endo Pharmaceuticals
Sun Pharmaceutical Industries
Tris Pharma
Indivior

Segment by Type
Fentanyl
Codeine
Morphine
Others

Segment by Application
Hospital Pharmacy
Online Pharmacy
Retail Pharmacy

Each chapter of the report provides detailed information for readers to understand the Opioid Receptor Agonist market further:
Chapter 1: Opioid Receptor Agonist Market Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 2: Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers' commercial date of Opioid Receptor Agonist, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Opioid Receptor Agonist industry.
Chapter 3: Opioid Receptor Agonist Market Historical (2018-2022) and forecast (2023-2029) volume and revenue analysis of Opioid Receptor Agonist in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4: Opioid Receptor Agonist Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 5 to 9: Opioid Receptor Agonist Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10: Manufacturers' Outline, covering company's basic information like headquarter, contact information, major business, Opioid Receptor Agonist introduction, etc. Opioid Receptor Agonist Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11: Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12: Market Channel, Distributors and Customers are listed.
Chapter 13: QYResearch's Conclusions of Opioid Receptor Agonist market based on comprehensive survey.
Chapter 14: Methodology and Data Sources.

Some of the Key Questions Answered in this Report:
1.What is the Opioid Receptor Agonist market size at the regional and country-level
2.What are the key drivers, restraints, opportunities, and challenges of the Opioid Receptor Agonist market, and how they are expected to impact the market
3.What is the global (North America, Europe, Asia-Pacific, Latin America, Middle East and Africa) sales value, production value, consumption value, import and export of Opioid Receptor Agonist
4.Who are the global key manufacturers of the Opioid Receptor Agonist Industry? How is their operating situation (capacity, production, sales, price, cost, gross, and revenue)
5.What are the Opioid Receptor Agonist market opportunities and threats faced by the vendors in the global Opioid Receptor Agonist Industry
6.Which application/end-user or product type may seek incremental growth prospects? What is the market share of each type and application
7.What focused approach and constraints are holding the Opioid Receptor Agonist market
8.What are the different sales, marketing, and distribution channels in the global industry
9.What are the upstream raw materials and of Opioid Receptor Agonist along with the manufacturing process of Opioid Receptor Agonist
10.What are the key market trends impacting the growth of the Opioid Receptor Agonist market
11.Economic impact on the Opioid Receptor Agonist industry and development trend of the Opioid Receptor Agonist industry
12.What are the Opioid Receptor Agonist market opportunities, market risk, and market overview of the Opioid Receptor Agonist market

Our Service:
1.Express Delivery Report Service
2.More than 16 years of vast experience
3.Establish offices in 6 countries
4.Operation for 24 * 7 & 365 days
5.Owns large database
6.In-depth and comprehensive analysis
7.Professional and timely after-sales service

To contact us and get this report: https://www.qyresearch.com/contact-us

About Us:
QYResearch founded in California, USA in 2007, which is a leading global market research and consulting company. Our primary business include market research reports, custom reports, commissioned research, IPO consultancy, business plans, etc. With over 16 years of experience and a dedicated research team, we are well placed to provide useful information and data for your business, and we have established offices in 6 countries (include United States, Germany, Japan, Korea, China and India) and business partners in over 30 countries. We have provided industrial information services to more than 60,000 companies in over the world.

Contact Us:
QY Research Inc.
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
EN: https://www.qyresearch.com
Tel: 001-626-842-1666(US) 0086-155 2126 6108(Intl)
E-mail: global@qyresearch.com
JP: https://www.qyresearch.co.jp

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Opioid Receptor Agonist Market Research Report 2023-2029 here

News-ID: 3223354 • Views:

More Releases from QY Research Inc.

High Power CW DFB Laser Market Report 2025-2031: Size, Analysis & Outlook | QYResearch
High Power CW DFB Laser Market Report 2025-2031: Size, Analysis & Outlook | QYRe …
The global market for High Power CW DFB Laser was estimated to be worth US$ 1821 million in 2024 and is forecast to a readjusted size of US$ 4289 million by 2031 with a CAGR of 14.4% during the forecast period 2025-2031. Global Leading Market Research Publisher QYResearch announces the release of its latest report "High Power CW DFB Laser - Global Market Share and Ranking, Overall Sales and Demand Forecast
Global Programmable Bidirectional DC Power Supply Market Size, Share & Forecast 2025-2031
Global Programmable Bidirectional DC Power Supply Market Size, Share & Forecast …
The global market for Programmable Bidirectional DC Power Supply was estimated to be worth US$ 116 million in 2024 and is forecast to a readjusted size of US$ 349 million by 2031 with a CAGR of 17.0% during the forecast period 2025-2031. Global Leading Market Research Publisher QYResearch announces the release of its latest report "Programmable Bidirectional DC Power Supply - Global Market Share and Ranking, Overall Sales and Demand Forecast
Global Liquid-Cooling BESS Container Market Size, Share & Forecast 2025-2031
Global Liquid-Cooling BESS Container Market Size, Share & Forecast 2025-2031
Unlock the Future of the Liquid-Cooling BESS Container Market: Comprehensive Global Market Report 2025-2031 Global leading market research publisher QYResearch published the release of its latest report, "Liquid-Cooling BESS Container - Global Market Share, Ranking, Sales, and Demand Forecast 2025-2031". This in-depth report provides a complete analysis of the global Liquid-Cooling BESS Container market, offering critical insights into market size, share, demand, industry development status, and future forecasts. Whether you're a
Global Network Interface Controller Chip Market Size, Share & Forecast 2025-2031
Global Network Interface Controller Chip Market Size, Share & Forecast 2025-2031
Unlock the Future of the Network Interface Controller Chip Market: Comprehensive Global Market Report 2025-2031 Global leading market research publisher QYResearch published the release of its latest report, "Network Interface Controller Chip - Global Market Share, Ranking, Sales, and Demand Forecast 2025-2031". This in-depth report provides a complete analysis of the global Network Interface Controller Chip market, offering critical insights into market size, share, demand, industry development status, and future forecasts.

All 5 Releases


More Releases for Opioid

Rising Opioid Use For Pain Management Fuels Growth In Opioid-Induced Constipatio …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Opioid-Induced Constipation Treatment Market Size Valuation Forecast: What Will the Market Be Worth by 2025? The market size for treatment of opioid-induced constipation has seen a substantial growth recently. It is expected to escalate from a solid $1.78 billion in 2024 to an impressive $1.9 billion in 2025, exhibiting
Growing Number Of Opioid Addiction Cases: Strategic Insights Driving Opioid Use …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. How Large Will the Opioid Use Disorder (OUD) Market Size By 2025? The market size for opioid use disorder (OUD) has experienced a quick expansion in the past few years. The growth is projected to rise from $3.96 billion in 2024 to $4.39 billion in 2025, boasting a compound
Key Influencer in the Opioid-Induced Constipation Treatment Market 2025: Rising …
What combination of drivers is leading to accelerated growth in the opioid-induced constipation treatment market? The rise in opioid administration for cancer and non-cancer pain is expected to drive the growth of the opioid-induced constipation (OIC) treatment market. Opioids are commonly used for managing moderate to severe pain, but they can cause constipation. OIC treatments are vital for improving the quality of life for patients on opioids, allowing them to maintain
Top Factor Driving Opioid Use Disorder (OUD) Market Growth in 2025: Growing Numb …
How Are the key drivers contributing to the expansion of the opioid use disorder (oud) market? The rise in instances of opioid dependency is set to fuel the expansion of the opioid use disorder (OUD) market. Opioid dependency defines a health concern marked by habitual and uncontrolled opioid consumption which negatively impacts health. These opioids can generate feelings of bliss and relief from pain, but continued usage often results in tolerance
What's Driving the Opioid-Induced Constipation Treatment Market 2025-2034: Risin …
What Are the Projections for the Size and Growth Rate of the Opioid-Induced Constipation Treatment Market? The market size for treatments of constipation caused by opioids has seen robust growth lately. The forecasted growth indicates an increase from $1.78 billion in 2024 to $1.9 billion in 2025, representing a compound annual growth rate (CAGR) of 7.0%. This past growth is associated with a growing elderly population, individualized treatments for OIC, the
MEDICAL MARIJUANA AND THE OPIOID CRISIS
Marijuana from the Cannabis plant is classified as a psychoactive drug used for medical or recreational purposes. Although it has been used for decades, in the U.S., it is still illegal under federal law to use and possess marijuana. Get PDF Sample Brochure of this report at: https://decisionmarketreports.com/request-sample/1247622 Nevertheless, at the state level, policies regarding the medical and recreational use of Cannabis vary greatly, and in many states conflict significantly with federal